Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial

James Chih Hsin Yang, Jin Yuan Shih, Wu Chou Su, Te Chun Hsia, Chun Ming Tsai, Sai Hong Ignatius Ou, Chung Jen Yu, Gee Chen Chang, Ching Liang Ho, Lecia V. Sequist, Arkadiusz Z. Dudek, Mehdi Shahidi, Xiuyu Julie Cong, Robert M. Lorence, Pan Chyr Yang, Vincent A. Miller

研究成果: Article同行評審

341 引文 斯高帕斯(Scopus)

指紋

深入研究「Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): A phase 2 trial」主題。共同形成了獨特的指紋。

Medicine & Life Sciences